US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

38.95

-0.4244-1.08%

Volume:698

Turnover:27.20K

Market Cap:7.79M

PE:- -

High:38.97

Open:38.97

Low:38.95

Close:39.37

52wk High:43.01

52wk Low:25.42

Shares:200.00K

Float Shares:200.00K

Volume Ratio:0.35

T/O Rate:0.35%

Dividend:0.32

Dividend Rate:0.82%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Black Diamond Therapeutics Q2 Net Loss Narrows Year over Year

EyePoint Pharmaceuticals Q2 Revenue Drops on Lower License Income

Seres Therapeutics Q2 Net Income Turns Positive on VOWST Sale Gain

Analysts Conflicted on These Healthcare Names: Dianthus Therapeutics (DNTH) and American Well (AMWL)

Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH) and Viridian Therapeutics (VRDN)

Dianthus Therapeutics Q2 Net Loss Widens as R&D Costs Rise

Praxis Precision Medicines Grants 7,318 RSUs to 29 New Employees Under 2024 Inducement Plan

Dianthus Therapeutics - Reports $1.20 Bln Cash as of June 30, 2026, Provides Expected Runway into 2030

THOMSON REUTERS

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results

THOMSON REUTERS

Praxis Precision Medicines, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Dianthus Therapeutics Inc Q2 Operating Expenses USD 62.243 Million

THOMSON REUTERS

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Praxis Precision Medicines Inc Expected to Post a Loss of $3.66 a Share - Earnings Preview

Dianthus Therapeutics - Dnth312 Expected to be Phase 1 Ready by Year-End 2027

THOMSON REUTERS

Dianthus Therapeutics - Dnth312 Targets Inhibition of Ac1s and Baff/April Pathways for Autoimmune Diseases

THOMSON REUTERS

Dianthus Therapeutics - Dnth312 Demonstrates Similar Immunoglobulin Reductions to Povetacicept in Nhps

THOMSON REUTERS

Early Backer of Humanoid Robot Startup Sets Sights on Chengdu Brain-Computer Interface Company

New Standards Set to Boost Industry Growth and Consumer Wellbeing

Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72

Dianthus Therapeutics Inc Expected to Post a Loss of 86 Cents a Share - Earnings Preview

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/IBRN/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":38.95,"timestamp":1788539288706,"preClose":39.3744,"halted":0,"volume":698,"delay":0,"changeRate":-0.010778576943394656,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"Trading","change":-0.4244,"latestTime":"09-04 12:38:15 EDT","open":38.97,"high":38.97,"low":38.95,"amount":27199.85246,"amplitude":0.000508,"askPrice":39.07,"askSize":300,"bidPrice":38.79,"bidSize":300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788552000000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":39.3744,"sharesOutstanding":150000,"nav":39.408165,"aum":7881633,"dividendRate":0.008203,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":39.38,"preClose":39.3744,"latestTime":"16:10 EDT","volume":6,"amount":235.9776,"timestamp":1788466204933,"change":0.0056,"changeRate":0.000142,"amplitude":0},"volumeRatio":0.347684,"impliedVol":0.0707,"impliedVolPercentile":0.246},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.347684,"shares":200000,"dividePrice":0.3195,"high":38.97,"amplitude":0.000508,"preClose":39.3744,"low":38.95,"week52Low":25.4196,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":38.95,"eps":0,"divideRate":0.008203,"volume":698,"delay":0,"ttmEps":0,"open":38.97,"prevYearClose":32.3193,"prevWeekClose":39.2301,"prevMonthClose":38.9601,"prevQuarterClose":38.8263,"fiveDayClose":39.2301,"twentyDayClose":38.8576,"sixtyDayClose":33.9605},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657352038","title":"Black Diamond Therapeutics Q2 Net Loss Narrows Year over Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2657352038","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657352038?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:08","pubTimestamp":1785960515,"startTime":"0","endTime":"0","summary":"Black Diamond Therapeutics Q2 net loss narrows year over yearOverviewUS oncology developer's Q2 net loss narrowed yr/yrCompany presented positive Phase 2 silevertinib results in NSCLC at ASCO 2026Cash","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","BK4139","TRDA","IBRN","DNTH","BK4563","IMRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657549329","title":"EyePoint Pharmaceuticals Q2 Revenue Drops on Lower License Income","url":"https://stock-news.laohu8.com/highlight/detail?id=2657549329","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657549329?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:24","pubTimestamp":1785929053,"startTime":"0","endTime":"0","summary":"EyePoint Pharmaceuticals Q2 revenue drops on lower license incomeOverviewUS retinal disease drug developer's Q2 revenue fell sharply yr/yr on lower license revenueQ2 operating expenses rose, reflectin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420J5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","STOK","IBRN","LU0889565916.HKD","EYPT","DNTH","BK4585","OCUL","BK4588","LU0109394709.USD","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657354674","title":"Seres Therapeutics Q2 Net Income Turns Positive on VOWST Sale Gain","url":"https://stock-news.laohu8.com/highlight/detail?id=2657354674","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657354674?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:19","pubTimestamp":1785928770,"startTime":"0","endTime":"0","summary":"Seres Therapeutics Q2 net income turns positive on VOWST sale gainOverviewUS biotechnology firm's Q2 net income turned positive, driven by VOWST business sale gainOperating expenses for Q2 fell yr/yr ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4420IF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBRN","DNTH","KROS","MCRB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657953475","title":"Analysts Conflicted on These Healthcare Names: Dianthus Therapeutics (DNTH) and American Well (AMWL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657953475","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657953475?lang=en_us&edition=fundamental","pubTime":"2026-08-05 08:10","pubTimestamp":1785888606,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Dianthus Therapeutics (DNTH) and American Well (AM...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-dianthus-therapeutics-dnth-and-american-well-amwl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-dianthus-therapeutics-dnth-and-american-well-amwl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","IBRN","AMWL","HCSG","BK4588","XBI","XLV","LABU","BK4167","BK4139","LU0128526141.USD","BK4137","BK4585","BK4581","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567780","title":"Analysts Offer Insights on Healthcare Companies: Dianthus Therapeutics (DNTH) and Viridian Therapeutics (VRDN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567780?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:20","pubTimestamp":1785878408,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Dianthus Therapeutics (DNTH) and Viridian Therapeuti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dianthus-therapeutics-dnth-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dianthus-therapeutics-dnth-and-viridian-therapeutics-vrdn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4585","XLV","BK4588","BK4581","DNTH","LU0128526141.USD","XBI","LABU","IBRN","HCSG","BK4137","LU0029874061.USD","VRDN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657569783","title":"Dianthus Therapeutics Q2 Net Loss Widens as R&D Costs Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2657569783","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657569783?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:09","pubTimestamp":1785874166,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Q2 net loss widens as R&D costs riseOverviewUS biotech firm reported Q2 net loss widened to $50.2 mlnOperating expenses for Q2 rose, driven by higher R&D costs for clinical progr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N44113F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PVLA","IBRN","KROS","BK4505","BK4539","DNTH","DSGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657693385","title":"Praxis Precision Medicines Grants 7,318 RSUs to 29 New Employees Under 2024 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2657693385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657693385?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:02","pubTimestamp":1785873760,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines grants 7,318 RSUs to 29 new employees under 2024 inducement planPraxis Precision Medicines granted restricted stock units covering 7,318 common shares to 29 new non-executiv","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL2Gq3xh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B2B36J28.USD","SG9999014039.USD","BCDF","PRAX","IE00BJJMRZ35.SGD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014005.SGD","SG9999014013.SGD","LU0314104364.USD","BK4139","BK4112","IE0009355771.USD","IBRN","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","NDAQ","LU2210150020.SGD","LU0889565916.HKD","IE00B4R5TH58.HKD","IE00B3QW5Z07.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4588","LU2095319765.USD","IE00BKPKM429.USD","IE0002141913.USD","IE00BJT1NW94.SGD","LU0109394709.USD","SG9999014021.USD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657856473","title":"Dianthus Therapeutics - Reports $1.20 Bln Cash as of June 30, 2026, Provides Expected Runway into 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=2657856473","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657856473?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873662,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA59Z0BL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657756986","title":"Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2657756986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657756986?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873662,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA59Z0BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657791566","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657791566","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657791566?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873661,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUABCBZ25:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B2B36J28.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","IBRN","LU0889565916.HKD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4139","PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657737566","title":"Dianthus Therapeutics Inc Q2 Operating Expenses USD 62.243 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657737566","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657737566?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873661,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nPLXJKZ0MB:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657678635","title":"Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657678635","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657678635?lang=en_us&edition=fundamental","pubTime":"2026-08-05 04:01","pubTimestamp":1785873660,"startTime":"0","endTime":"0","summary":"Investor Contact:. 857-702-9452. Media Contact:. Dan Ferry. LifeSci Advisors. 617-430-7576","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/04/3338776/0/en/Praxis-Precision-Medicines-Inc-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0009355771.USD","LU0320765992.SGD","IE00B2B36J28.USD","LCLG","LU0109394709.USD","PRAX","IE0002141913.USD","CNS","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0889565916.HKD","ASO","IE00BJJMRZ35.SGD","BK4135","BK4200","IBRN","BK4561","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656590215","title":"Praxis Precision Medicines Inc Expected to Post a Loss of $3.66 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656590215","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656590215?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:18","pubTimestamp":1785849486,"startTime":"0","endTime":"0","summary":"Praxis Precision Medicines Inc <PRAX.OQ> expected to post a loss of $3.66 a share - Earnings PreviewPraxis Precision Medicines IncPRAX.OQPRAX.Ois expected to  show no change in quarterly revenue when ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4411OR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","IE0002141913.USD","LU0889565916.HKD","IE0009355771.USD","IE00B2B36J28.USD","IBRN","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","BK4139","PRAX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656753021","title":"Dianthus Therapeutics - Dnth312 Expected to be Phase 1 Ready by Year-End 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2656753021","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656753021?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:09","pubTimestamp":1785841791,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44107X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DNTH","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656553079","title":"Dianthus Therapeutics - Dnth312 Targets Inhibition of Ac1s and Baff/April Pathways for Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2656553079","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656553079?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:09","pubTimestamp":1785841791,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44107X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","IBRN","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656530762","title":"Dianthus Therapeutics - Dnth312 Demonstrates Similar Immunoglobulin Reductions to Povetacicept in Nhps","url":"https://stock-news.laohu8.com/highlight/detail?id=2656530762","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656530762?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:09","pubTimestamp":1785841791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44107X:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBRN","BK4139","DNTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100243579","title":"Early Backer of Humanoid Robot Startup Sets Sights on Chengdu Brain-Computer Interface Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1100243579","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100243579?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:14","pubTimestamp":1785838478,"startTime":"0","endTime":"0","summary":"Wabo Technology Co., Ltd. recently announced the completion of its angel round of financing, featuring a notably prestigious lineup of investors. Participants include Vertex Ventures, under...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","688836","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148426331","title":"New Standards Set to Boost Industry Growth and Consumer Wellbeing","url":"https://stock-news.laohu8.com/highlight/detail?id=1148426331","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148426331?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:40","pubTimestamp":1785800457,"startTime":"0","endTime":"0","summary":"Starting August 1, a total of 488 national standards, including 46 mandatory ones and 442 recommended ones, will be implemented, as announced by the State Administration for Market Regulation...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","IVRS","RAYS","BK4020","MAKX","IBRN","GNSS","ARVR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300056","title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300056","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300056?lang=en_us&edition=fundamental","pubTime":"2026-08-04 07:10","pubTimestamp":1785798604,"startTime":"0","endTime":"0","summary":"Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $98,821.72David Joseph Gaffin, EVP and chief legal officer, sold 2,034 ordinary shares on Aug. 3, 2026 at USD 48.58.His direct stake fell t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL9zXC08:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin Sells 2,034 Shares for $98,821.72","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","ALKS","FBT","PSIL","BK4139","IBRN","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300873","title":"Dianthus Therapeutics Inc Expected to Post a Loss of 86 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300873","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300873?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:12","pubTimestamp":1785795140,"startTime":"0","endTime":"0","summary":"Dianthus Therapeutics Inc <DNTH.OQ> expected to post a loss of86cents a share - Earnings PreviewDianthus Therapeutics IncDNTH.OQDNTH.Ois expected to  show a rise in quarterly revenue when it reports  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4402MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","BK4139","DNTH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}